These authorizations enable the simultaneous launch of recruitment for these international studies, which should be completed in the first half of 2023. The INSIGHT and INSIGHT 2 randomized, ...
The ferroptosis targeting therapy market is growing due to its potential in treating drug-resistant cancers and neurodegenerative diseases. Opportunities include combining therapies to enhance ...
A key advantage of using RWD in a natural history study is gaining diverse and representative data. RWD covers broad patient populations, including those with comorbidities, various age groups, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results